Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt.
Analytical Chemistry Department, Faculty of Pharmacy, Helwan University, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2014;121:313-23. doi: 10.1016/j.saa.2013.10.090. Epub 2013 Nov 6.
A novel spectrophotometric technique was developed for the simultaneous determination of ternary mixtures, without prior separation steps. This technique was called successive spectrophotometric resolution technique. The technique was based on either the successive ratio subtraction or successive derivative subtraction. The mathematical explanation of the procedure was illustrated. In order to evaluate the applicability of the methods a model data as well as an experimental data were tested. The results from experimental data related to the simultaneous spectrophotometric determination of lidocaine hydrochloride (LH), calcium dobesilate (CD) and dexamethasone acetate (DA); in the presence of hydroquinone (HQ), the degradation product of calcium dobesilate were discussed. The proposed drugs were determined at their maxima 202 nm, 305 nm, 239 nm and 225 nm for LH, CD, DA and HQ respectively; by successive ratio subtraction coupled with constant multiplication method to obtain the zero order absorption spectra, while by applying successive derivative subtraction they were determined at their first derivative spectra at 210 nm for LH, 320 nm or P(292-320) for CD, 256 nm or P(225-252) for DA and P(220-233) for HQ respectively. The calibration curves were linear over the concentration range of 2-20 μg/mL for both LH and DA, 6-50 μg/mL for CD, and 3-40 μg/mL for HQ. The proposed methods were checked using laboratory-prepared mixtures and were successfully applied for the analysis of pharmaceutical formulation containing the cited drugs with no interference from other dosage form additives. The proposed methods were validated according to the ICH guidelines. The obtained results were statistically compared with those of the official BP methods for LH, DA, and CD, and with the official USP method for HQ; using student t-test, F-test, and one way ANOVA, showing no significant difference with respect to accuracy and precision.
一种新的分光光度技术被开发用于同时测定三元混合物,无需预先分离步骤。该技术称为连续分光分辨率技术。该技术基于连续比差减或连续导数差减。说明了该方法的数学解释。为了评估方法的适用性,测试了模型数据和实验数据。实验数据与盐酸利多卡因(LH)、二羟苯磺酸钙(CD)和醋酸地塞米松(DA)的同时分光光度测定有关的结果进行了讨论;在二羟苯磺酸钙的降解产物氢醌(HQ)存在下。所提议的药物分别在 202nm、305nm、239nm 和 225nm 处测定其最大吸收,即 LH、CD、DA 和 HQ 的最大吸收;通过连续比差减结合常数乘法法获得零阶吸收光谱,而通过应用连续导数差减法,它们在 210nm 处测定 LH 的一阶导数光谱,在 320nm 或 P(292-320)处测定 CD 的一阶导数光谱,在 256nm 或 P(225-252)处测定 DA 的一阶导数光谱,在 P(220-233)处测定 HQ 的一阶导数光谱。校准曲线在 LH 和 DA 的浓度范围为 2-20μg/mL,CD 的浓度范围为 6-50μg/mL,HQ 的浓度范围为 3-40μg/mL时呈线性。该方法经实验室制备的混合物验证,并成功应用于含有所述药物的药物制剂的分析,无其他剂型添加剂的干扰。该方法按照 ICH 指南进行了验证。所得结果与 LH、DA 和 CD 的官方 BP 方法以及 HQ 的官方 USP 方法进行了统计学比较;使用学生 t 检验、F 检验和单向方差分析,在准确性和精密度方面没有显著差异。